124 related articles for article (PubMed ID: 11758945)
1. Clinical value of lung uptake of iodine-123 metaiodobenzylguanidine (MIBG), a myocardial sympathetic nerve imaging agent, in patients with chronic heart failure.
Mu X; Hasegawa S; Yoshioka J; Maruyama A; Maruyama K; Paul AK; Yamaguchi H; Morozumi T; Hashimoto K; Kusuoka H; Nishimura T
Ann Nucl Med; 2001 Oct; 15(5):411-6. PubMed ID: 11758945
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification assessed by combined lung and heart iodine-123 metaiodobenzylguanidine uptake in patients with idiopathic dilated cardiomyopathy.
Kamiyoshi Y; Yazaki Y; Urushibata K; Koizumu T; Kasai H; Izawa A; Kinoshita O; Hongo M; Ikeda U
Am J Cardiol; 2008 May; 101(10):1482-6. PubMed ID: 18471462
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Anastasiou-Nana MI; Terrovitis JV; Athanasoulis T; Karaloizos L; Geramoutsos A; Pappa L; Tsagalou EP; Efentakis S; Nanas JN
Am J Cardiol; 2005 Aug; 96(3):427-31. PubMed ID: 16054475
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of 123I-MIBG after acute myocardial infarction and reperfusion therapy.
Bengel FM; Barthel P; Matsunari I; Schmidt G; Schwaiger M
J Nucl Med; 1999 Jun; 40(6):904-10. PubMed ID: 10452304
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
[TBL] [Abstract][Full Text] [Related]
6. Clinical relationship of myocardial sympathetic nervous activity to cardiovascular functions in chronic heart failure: assessment by myocardial scintigraphy with 123I-metaiodobenzylguanidine.
Wada Y; Miura M; Fujiwara S; Mori S; Seiji K; Kimura T
Tohoku J Exp Med; 2003 Dec; 201(4):261-70. PubMed ID: 14690018
[TBL] [Abstract][Full Text] [Related]
7. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.
Tamaki S; Yamada T; Okuyama Y; Morita T; Sanada S; Tsukamoto Y; Masuda M; Okuda K; Iwasaki Y; Yasui T; Hori M; Fukunami M
J Am Coll Cardiol; 2009 Feb; 53(5):426-35. PubMed ID: 19179201
[TBL] [Abstract][Full Text] [Related]
8. Extension of myocardial necrosis differently affects MIBG retention in heart failure caused by ischaemic heart disease or by dilated cardiomyopathy.
Marini C; Giorgetti A; Gimelli A; Kusch A; Sereni N; L'abbate A; Marzullo P; Sambuceti G
Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):682-8. PubMed ID: 15747157
[TBL] [Abstract][Full Text] [Related]
9. Assessment of central chemosensitivity and cardiac sympathetic nerve activity using I-123 MIBG imaging in central sleep apnea syndrome in patients with dilated cardiomyopathy.
Meguro K; Toyama T; Adachi H; Ohshima S; Taniguchi K; Nagai R
Ann Nucl Med; 2007 Jan; 21(1):73-8. PubMed ID: 17373339
[TBL] [Abstract][Full Text] [Related]
10. Assessment of myocardial metaiodobenzylguanidine uptake and its relation to left ventricular systolic and diastolic functional parameters in dilated cardiomyopathy.
Ha JW; Lee JD; Chung N; Jang Y; Cho SH; Kim BS; Rim SJ; Shim WH; Cho SY; Kim SS
Yonsei Med J; 1999 Jun; 40(3):199-206. PubMed ID: 10412329
[TBL] [Abstract][Full Text] [Related]
11. Relationship between late ventricular potentials and myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with dilated cardiomyopathy with mild to moderate heart failure: results of a prospective study of sudden death events.
Kasama S; Toyama T; Kaneko Y; Iwasaki T; Sumino H; Kumakura H; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1056-64. PubMed ID: 22415599
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis].
Li S; Ikeda J; Takita T; Sekiguchi Y; Demachi J; Chikama H; Goto A; Shirato K
J Cardiol; 1998 Nov; 32(5):323-9. PubMed ID: 9864689
[TBL] [Abstract][Full Text] [Related]
13. Prediction of adverse cardiac events in dilated cardiomyopathy using cardiac T2* MRI and MIBG scintigraphy.
Nagao M; Baba S; Yonezawa M; Yamasaki Y; Kamitani T; Isoda T; Kawanami S; Maruoka Y; Kitamura Y; Abe K; Higo T; Sunagawa K; Honda H
Int J Cardiovasc Imaging; 2015 Feb; 31(2):399-407. PubMed ID: 25348658
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of cardiac sympathetic nerve activity in children with chronic heart failure using quantitative iodine-123 metaiodobenzylguanidine imaging].
Karasawa K; Ayusawa M; Noto N; Sumitomo N; Okada T; Harada K
J Cardiol; 2000 Dec; 36(6):387-95. PubMed ID: 11190582
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].
Narita M; Kurihara T
J Cardiol; 1998 Jun; 31(6):343-9. PubMed ID: 9666388
[TBL] [Abstract][Full Text] [Related]
16. Impairment of Iodine-123-Metaiodobenzylguanidine (
Higo K; Kubota K; Miyanaga S; Miyata M; Nakajo M; Jinguji M; Ohishi M
Int Heart J; 2018 Jan; 59(1):112-119. PubMed ID: 29332912
[TBL] [Abstract][Full Text] [Related]
17. Relationship between cardiac 123I-metaiodobenzylguanidine imaging and the transcardiac gradient of neurohumoral factors in patients with dilated cardiomyopathy.
Matsui T; Tsutamoto T; Kinoshita M
Jpn Circ J; 2001 Dec; 65(12):1041-6. PubMed ID: 11767995
[TBL] [Abstract][Full Text] [Related]
18. [Estimation of 123I-metaiodobenzylguanidine lung uptake in heart and lung diseases--with reference to lung uptake ratio and decrease of lung uptake].
Fujii T; Tanaka M; Yazaki Y; Kitabayashi H; Koizumi T; Sekiguchi M; Gomi T; Yano K; Itoh A
Kaku Igaku; 1997 Nov; 34(11):1005-11. PubMed ID: 9455040
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.
Takeishi Y; Atsumi H; Fujiwara S; Takahashi K; Tomoike H
J Nucl Med; 1997 Jul; 38(7):1085-9. PubMed ID: 9225795
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of myocardial MIBG scintigraphy findings in patients with cardiomyopathy--importance of background correction for quantification of MIBG activity.
Imamura Y; Fukuyama T
Ann Nucl Med; 2002 Sep; 16(6):387-93. PubMed ID: 12416577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
